Daawada 'Enap-N' - muuqaalada codsiga

Kiniiniga "Enap-H" tijaabiso ay saamayn antihypertensive, ay sabab u tahay xaqiiqda ah in uu jiro xanibaadda ah anaprilatom ACE. Enalapril, taas oo ah qayb ka mid ah ayaa sheegay in diyaarinta, ku lug leh hoos u aldosterone iyo angiotensin II ee dhiigga, sida kobciyaa nidaamka jirka vasodepressor pressor oo uu hakiyo (Raas). Thanks in ay kordhisaa formation of factor endothelial vascular. Tani waxa ay yaraynaysaa wax iska caabin ah durugsan, si robot la fududeeyey ventricle bidix, sababa dhaca ee hypertrophy, ilmogaleenka iyo hoos dhaawac gacanta myocardial waxaa loogu hortegi karaa. horumar ah hemodynamics coronary, kordheen caabiga hypoxia muruqyada wadnaha iyo in la yareeyo dhacdooyinka baarutaan ventricular naf-gooyada ah. Sababo la xaqiiqada ah in enalapril waa la dhimay zone galleeyda ka dib markii Wadnaxanuun ku myocardial oo fiicnaaday-shiid muruqa wadnaha ee halabuurka ah ee kiniiniyada "Enap-H". Si kastaba ha ahaatee, ma jirto dhiig gareeyeen halkii daqiiqo, ama inta jeer ee foosha ee muruqa wadnaha, ma beddeli. Mararka ay dhacdo in ay jiraan hypertension chronic, cudurka cerebrovascular, ayaa sheegay in walax yaraynaysaa iska caabin renovascular, oo wuxuu sameynayaa in ay kicin wareegga dhiigga ee kelyaha, sodium iyo biyo Digo ah, heerka sifeynta glomerular, kaydiya potassium ee jirka.

At diyaarinta soo dhawaynta si joogto ah "Enap-H" gobolka iyo hagaajinaysaa caafimaadka dadka qaba cudurrada wadnaha iyo sidoo kale si weyn u yareysaa dhimashada in joogitaanka gabsiiya wadnaha. Natiijada la isticmaalayo daroogada taasi ku xiran tahay ma ku da'da iyo jinsiga bukaanka. Waxa uu sidoo kale leeyahay ma saamayn xun ku baruurta ama carbohydrate-shiid midkood oo sababa gebihaanba ma jirto cillad galmada ee jirka.

Saamaynta daweynta ka dib markii maamulka "Enap-H" dhacdaa saacad gudahood oo socday muddo ku saabsan 24-ka saac.

Tilmaamayaasha

Waxaa lagu talinayaa in la isticmaalo daroogada this ee hypertension renovascular joogaan, hypertension lagama maarmaanka ah, iyo dabcan, la degree mid ka mid ah wadnaha oo shaqadiisa gaba. In si ay u hoos u dhigi horumarinta wadnaha waxa ay sidoo kale waxaa lagu talinayaa in ay qaataan daawada "Enap-H". Waxay ka caawisaa ma aha oo kaliya in lagu daaweeyo, laakiin sidoo kale si loo yareeyo dhacdooyinka angina deganayn iyo yaraynaysaa halista ah ee Wadnaxanuun myocardial, kordhinayaan in ka hortaga myocardium ischaemic.

Diyaarinta "Enap-N" - hab adoo isticmaalaya

Kiniinnada ma yihiin dareere, iyo soo dhaweynta aan la xidhan cunaya. dose horudhac ah ka helay daroogada waa in aan ka badnayn 5 mg maalintii, iyo waxa laga yaabaa in si tartiib tartiib ah in la kordhiyo ilaa 20 mg, iyo xaalado gaar ah u daran, iyo ilaa 40 mg, kaas oo u qaybsan yahay laba talaabo. Haddii bukaanku leeyahay decompensation wadnaha ama hypertension daran, cadaadiska laga yaabaa in si weyn u dhimay bilowga daweynta. Taasi waa sababta waa in aan marka hore qaado qiyaas yar, oo had iyo jeer iyada oo ay kormeerayaan dhakhtar.

Haddii bukaanka waxaa lagu daaweeyaa diuretics, isticmaalka daroogada "Enap-N" keeni karaa hoos u dhac in mugga dhiigga oo ay jirto halista ah ee dhacdo of hypotension. Xaaladdan oo kale, dose hore qaadan kartaa oo ka yar 5 mg / maalintiiba.

lacagta loo baahan yahay ee daroogada ah ee ilmo kasta oo dawarsanayay, si gaar ah. Haddii ilmaha miisaanka 20-50 kg, ka dibna dose hore waa in aanay noqon in ka badan 2.5 mg.

Sida kooxda saamayn muuqan kara wareer, isbedel xagga dhadhanka, daal. Waxa kale oo laga yaabaa in hoos u dhac ku dhiig xinjirowga sameeya oo leukocyte, Agranulocytosis iyo dhiig la'aan. dhacdo suurtogalka ah ee reactions orthostatic, hypotension, sii kordhaya xaddiga HOL in serum dhiigga, murqo.

Kiniiniga "Enap-N" - oo ku saabsan dib u eegista daroogada

Dadka si joogto ah u qaadan daroogada, soo jeedinaynaa in ay si fiican u yaraynaysaa cadaadiska, iyo ma aha in ay isticmaalka joogtada ah. khasaaro A of badan hal dhibic si ay xaqiiqada ah in daroogada magacaabi iyo dooran qiyaasta loo baahan yahay waxaa laga yaabaa in dhakhtarku kaliya.